Inventor · disambiguated record
Dirk Eulberg
Also filed as: EULBERG DIRK
18 granted patents·11 pending applications·60 citations·filing 2003–2020
93Inventor score
Top patents by PatentIndex Score
29 records- 0190US8314223B2SDF-1 binding nucleic acidsPURSCHKE WERNER·Filed 2009·Granted Nov 20, 2012·11 cites·10 claims
- 0289US8367629B2MCP-1 binding nucleic acids and use thereofNOXXON PHARMA AG·Filed 2008·Granted Feb 5, 2013·6 cites·14 claims
- 0386US8193159B2MCP-1 binding nucleic acidsPURSCHKE WERNER·Filed 2007·Granted Jun 5, 2012·6 cites·16 claims
- 0484US9387221B2SDF-1 binding nucleic acids and the use thereof in cancer treatmentNOXXON PHARMA AG·Filed 2015·Granted Jul 12, 2016·2 cites·20 claims
- 0584US8772257B2SDF-1 binding nucleic acids and the use thereofPURSCHKE WERNER·Filed 2008·Granted Jul 8, 2014·6 cites·22 claims
- 0684US8507456B2C5a binding nucleic acidsPURSCHKE WERNER·Filed 2008·Granted Aug 13, 2013·7 cites·67 claims
- 0780US9035038B2SDF-1 binding nucleic acidsNOXXON PHARMA AG·Filed 2012·Granted May 19, 2015·3 cites·18 claims
- 0878US10093934B2SDF-1 binding nucleic acids and the use thereof in cancer treatmentNOXXON PHARMA AG·Filed 2016·Granted Oct 9, 2018·1 cites·18 claims
- 0978US7750140B2Ghrelin binding nucleic acidsNOXXON PHARMA AG·Filed 2003·Granted Jul 6, 2010·11 cites·18 claims
- 1077US8691784B2MCP-1 binding nucleic acidsPURSCHKE WERNER·Filed 2012·Granted Apr 8, 2014·2 cites·21 claims
- 1174US8497250B2Use of spiegelmers to inhibit an intracellular target moleculeVATER AXEL·Filed 2006·Granted Jul 30, 2013·3 cites·28 claims
- 1273US9988636B2SDF-1 binding nucleic acids and the use thereofNOXXON PHARMA AG·Filed 2016·Granted Jun 5, 2018·1 cites·14 claims
- 1371US2021139909A1SDF-1 Binding Nucleic AcidsNOXXON PHARMA AG·Filed 2020·Application pending·0 cites
- 1470US8101734B2Ghrelin binding nucleic acidsJAROSCH FLORIAN·Filed 2006·Granted Jan 24, 2012·1 cites·11 claims
- 1563US9670491B2MCP-1 binding nucleic acidsNOXXON PHARMA AG·Filed 2014·Granted Jun 6, 2017·0 cites·17 claims
- 1662US10273480B2MCP-1 binding nucleic acidsNOXXON PHARMA AG·Filed 2017·Granted Apr 30, 2019·0 cites·20 claims
- 1760US2018163207A1SDF-1 Binding Nucleic AcidsNOXXON PHARMA AG·Filed 2017·Application pending·0 cites
- 1858US9822369B2SDF-1 binding nucleic acidsNOXXON PHARMA AG·Filed 2015·Granted Nov 21, 2017·0 cites·14 claims
- 1957US2014370034A1SDF-1 Binding Nucleic Acids and the Use ThereofNOXXON PHARMA AG·Filed 2014·Application pending·0 cites
- 2056US9074214B2Use of spiegelmersNOXXON PHARMA AG·Filed 2013·Granted Jul 7, 2015·0 cites·22 claims
- 2154US2013310442A1SDF-1 Binding Nucleic Acids and the use Thereof in Cancer TreatmentPURSCHKE WERNER·Filed 2011·Application pending·0 cites
- 2252US2007031840A1Nucleic acids specifically binding bioactive ghrelinNOXXON PHARMA AG·Filed 2004·Application pending·0 cites
- 2352US2015141496A1MCP-1 Binding Nucleic Acids and Use ThereofPURSCHKE WERNER·Filed 2014·Application pending·0 cites
- 2446US2017233737A1Means and Methods for the Treatment of NephropathyNOXXON PHARMA AG·Filed 2014·Application pending·0 cites
- 2544US2012115937A1Ghrelin binding nucleic acidsJAROSCH FLORIAN·Filed 2012·Application pending·0 cites
- 2642US2010261291A1Nucleic acids specifically binding bioactive ghrelinNOXXON PHARMA AG·Filed 2010·Application pending·0 cites
- 2741US2012083520A1Ghrelin binding nucleic acidsHELMLING STEFFEN·Filed 2010·Application pending·0 cites
- 2840US8383789B2Vasopressin-binding L-nucleic acidNOXXON PHARMA AG·Filed 2005·Granted Feb 26, 2013·0 cites·18 claims
- 2933US2012065254A1C5A binding nucleic acids and the use thereofJAROSCH FLORIAN·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →